人充满活力 发表于 2025-3-26 22:44:12

http://reply.papertrans.cn/67/6649/664870/664870_31.png

Working-Memory 发表于 2025-3-27 04:41:26

,An Introduction to „Recent Trends in the Biotechnology Industry: Development and Manufacturing of Rng drugs predicted to be biologics. From 1986 to 2014 several first-in-class, advance-in-class, and breakthrough designated therapeutic options were approved, with advanced therapies such as immuno-oncology and cell-based therapies being approved for several indications.

腐败 发表于 2025-3-27 09:02:42

http://reply.papertrans.cn/67/6649/664870/664870_33.png

谆谆教诲 发表于 2025-3-27 13:22:34

http://reply.papertrans.cn/67/6649/664870/664870_34.png

墙壁 发表于 2025-3-27 15:25:25

http://reply.papertrans.cn/67/6649/664870/664870_35.png

蒙太奇 发表于 2025-3-27 20:18:37

Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perstools for iPSC generation, and single-use controlled-environment systems for autologous cell production. These platforms address the challenges of manufacturing cell products in greater numbers while maintaining process robustness and product quality.

虚情假意 发表于 2025-3-28 01:20:37

http://reply.papertrans.cn/67/6649/664870/664870_37.png

burnish 发表于 2025-3-28 02:39:06

Book 2018for their synthesis and purification..In general, special volumes are edited by well-known guest editors. The series editor and publisher will however always be pleased to receive suggestions and supplementary information. Manuscripts are accepted in English.

Awning 发表于 2025-3-28 08:04:51

Manufacturing of Proteins and Antibodies: Chapter Downstream Processing Technologies,s. In this chapter we describe centrifugation and depth filtration harvesting methods, share strategies for harvest optimization, present recent developments in centrifugation scale-down models, and review alternative harvesting technologies.

表示问 发表于 2025-3-28 13:02:00

http://reply.papertrans.cn/67/6649/664870/664870_40.png
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins; Bob Kiss,Uwe Gottschalk,Michael Pohlsc